European Journal of Oncology Pharmacy
SJR0.211
BE
BEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.211 | Q4 | 30.1% | |
| 2024 | — | — | 0.179 | Q4 | 26.4% | |
| 2023 | — | — | 0.200 | Q4 | 35.0% | |
| 2022 | — | — | 0.144 | Q4 | 27.2% | |
| 2021 | — | — | 0.256 | Q3 | 46.6% | |
| 2020 | — | — | 0.105 | Q4 | 1.8% | |
| 2019 | — | — | 0.117 | Q4 | 16.4% | |
| 2018 | — | — | 0.137 | Q4 | 17.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1783-3914
ISSN
2032-7072
country
BEcoverage
2008-2015, 2017-2025